Frontier labs are ramping up indiscriminate bio data purchases, reshaping biotech startups
Ronangmi · x · 2026-10-07
A quoted thread notes that large frontier labs started buying bio data 6-12 months ago and the spend is ramping aggressively — labs are indiscriminate buyers with enormous budgets, unlike historical pharma data buyers.
- This shift will distort the bio startup market, fueling short-termist behavior around the capital firehose
- Unlike AI and robotics data labelers, bio data startups have a chance to emerge with businesses that don't rely on selling data
- The author imagines replaying the AI trade in bio: autonomous bio labs as the new hyperscalers, with OpenAI/Anthropic as proof the heavily capitalized moonshot strategy works
More from AGI Musings
- Why aren't foundation labs recording full infancies for training data? — jd_pressman · 2026-10-07
- In AI math, the bottleneck has shifted from finding proofs to verifying them — rohanpaul_ai · 2026-10-07
- Psych Scientist's Analogy: Today's LLMs Are Asimov's Psychohistory Bots, Not Real AI — changethisusername_ · 2026-10-07
- Dev: A $200/month AI Plan Beats Hiring 5 Top Programmers and a PM — sytelus · 2026-10-07
- Job Seeker Automates Hundreds of Applications, Bypasses Proctored Interviews as Hiring Breaks Down — sytelus · 2026-10-07
- Applied AI Has Only Existed for ~12 Months, So Newcomers Can Still Own a Niche — brandon_galang · 2026-10-07